Related Experiment Video
Updated: Oct 7, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
cADPR induced calcium influx mediates axonal degeneration caused by paclitaxel
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract:
Activation of the NAD hydrolase domain of Sarm1 mediates axonal degeneration caused by chemotherapy drugs, but the downstream events are unknown. In this issue, Li and colleagues (2021. J. Cell Biol.https://doi.org/10.1083/jcb.202106080) demonstrate that cADPR, a breakdown product of NAD, mediates paclitaxel-induced axonal degeneration by promoting influx of calcium into the axons.
Insights
Chemotherapy drug paclitaxel triggers axonal degeneration by activating Sarm1, leading to the breakdown product cyclic ADP-ribose (cADPR). This cADPR then causes calcium influx into axons, driving degeneration.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Sarm1 activation is known to mediate chemotherapy-induced axonal degeneration.
- The precise downstream molecular mechanisms following Sarm1 activation remain largely uncharacterized.
Purpose of the Study:
- To elucidate the downstream signaling pathway by which Sarm1 activation leads to axonal degeneration.
- To identify the specific molecules involved in paclitaxel-induced neurotoxicity.
Main Methods:
- Utilized cell culture models and biochemical assays to investigate the role of NAD metabolites.
- Examined the impact of cADPR on calcium homeostasis within axons.
Main Results:
- Demonstrated that cyclic ADP-ribose (cADPR), a breakdown product of NAD+, is a key mediator of paclitaxel-induced axonal degeneration.
- Showcased that cADPR promotes calcium influx into axons, a critical step in the degeneration process.
Conclusions:
- cADPR acts as a crucial downstream effector of Sarm1 activation in chemotherapy-induced axonal degeneration.
- Targeting the cADPR-mediated calcium influx pathway may offer therapeutic strategies against neurotoxicity.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs that Stabilize Microtubules

